跳至主要内容
临床试验/NCT02718040
NCT02718040已完成4 期

A Multi-Center Study to Evaluate the Perception of Facial Expressions Following Correction of Wrinkles and Folds in the Lower Face Using Emervel® Classic Lidocaine and Emervel® Deep Lidocaine

Galderma R&D0 个研究点目标入组 30 人开始时间: 2016年4月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
Galderma R&D
入组人数
30
主要终点
Number of Subjects With Naturalness of Expression in Motion (2D Video)

研究概览

简要总结

This study is designed to

  1. evaluate the naturalness of facial expressions in motion (2D video images), by treating investigator assessment
  2. evaluate naturalness of facial expressions (photographs), by treating investigator assessment
  3. evaluate perceived attractiveness and age of subject (2D videos), by treating investigator assessment
  4. evaluate aesthetic improvement, by subject and treating investigator assessments
  5. evaluate subject satisfaction
  6. evaluate nasolabial fold (NLF) severity, by treating investigator assessment
  7. evaluate marionette lines (MLs) severity, by treating investigator assessment
  8. evaluate dynamic facial strain in animation using 3D digital photogrammetric analysis
  9. evaluate all adverse events reported during the study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Seeking correction of bilateral NLFs: severe (i.e., bilateral WSRS = 3-4) or moderate (i.e., bilateral WSRS = 2-3) AND bilateral MLs: severe (i.e., WAS = 3-4) or moderate (i.e., WAS = 2-3).
  • Subjects of childbearing potential who agree to use medically accepted methods of contraception during the study and for 30 days following study completion.
  • Intent to undergo optimal correction of bilateral NLFs and MLs. Optimal correction is defined as the best possible aesthetic outcome as agreed to by the treating investigator and subject.

排除标准

  • Subject who presents with a severity of wrinkles or folds that require other treatments, e.g. laser treatment, chemical peeling, to achieve optimal correction.
  • Previous facial surgery, including aesthetic facial surgical therapy, liposuction or tattoo, in the treatment area.
  • Previous tissue augmenting therapy or contouring with permanent or non-permanent filler or fat-injection in the facial area.
  • Previous tissue revitalization treatment with neurotoxin in the facial area within 6 months before treatment.
  • Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel.
  • Known/previous allergy or hypersensitivity to local anaesthetics, e.g. lidocaine or other amide-type anaesthetics.
  • Known/previous allergy or hypersensitivity to gram-positive bacterial proteins.
  • Any medical condition that, in the opinion of the treating investigator, would make the subject unsuitable for inclusion (e.g. a chronic, relapsing or hereditary disease that may interfere with the outcome of the study).
  • Other condition preventing the subject from entering the study in the treating investigator's opinion, e.g. subjects not likely to avoid other facial cosmetic treatments, subjects anticipated to be unreliable, unavailable or incapable of understanding the study assessments or having unrealistic expectations of the treatment result.

结局指标

主要结局

Number of Subjects With Naturalness of Expression in Motion (2D Video)

时间窗: 42 days

Proportion of subjects having at least maintained naturalness of expression in lower face (naturalness is maintained or enhanced) based on 2D video assessment at Day 42, by treating investigator

次要结局

  • Number of Subjects With Naturalness of Expression (Photographs)(42 days)
  • Number of Subjects With Naturalness of Expression, Attractiveness AND Younger Appearance (2D Video)(42 days)
  • Number of Subjects Demonstrating Global Improvement (Treating Investigator)(42 days)
  • Wrinkle Severity (Assess MLs) - Proportion of Subjects With Bilateral Improvement of at Least 1 Grade in Wrinkle Severity(42 days)
  • Mean Change in Dynamic Facial Strain (Stretch) at Day 42 Compared to Baseline - NLF Combined (Global Dynamic Assessment)(baseline and 42 days)
  • Number of Subjects Reporting Global Improvement (Subject)(42 days)
  • Number of Subjects Reporting Satisfaction - The Overall Appearance of my Face Looks Natural(42 days)
  • Mean Change in Dynamic Facial Strain (Stretch) at Day 42 Compared to Baseline - ML Combined (Global Dynamic Assessment)(baseline and 42 days)
  • Wrinkle Severity (Assess NLFs) - Proportion of Subjects With Bilateral Improvement of at Least 1 Grade in Wrinkle Severity(42 days)

研究者

发起方
Galderma R&D
申办方类型
Industry
责任方
Sponsor

相似试验